Pasithea Therapeutics (KTTA) Other Non Operating Income (2022 - 2026)
Pasithea Therapeutics recorded quarterly Other Non Operating Income of -$9491.0 in Q1 2026, down 235.59% quarter-over-quarter from $7000.0 in Q3 2025, and down 235.59% year-over-year from $7000.0 in Q1 2025.
Pasithea Therapeutics' Other Non Operating Income history runs 5 years deep, the most recent figure standing at -$9491.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 235.59% year-over-year to -$9491.0; the TTM figure through Mar 2026 stood at $4509.0 (down 98.85% YoY), while the FY2025 annual figure was $7000.0, changed N/A from the prior year.
- Other Non Operating Income came in at -$9491.0 for Q1 2026 at Pasithea Therapeutics, down from $7000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $816086.0 in Q4 2022 to a low of -$9491.0 in Q1 2026.
- A 5-year average of $125102.3 and a median of $26000.0 in 2022 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income soared 2498.53% in 2024 and tumbled 235.59% in 2026, its largest moves.
- Pasithea Therapeutics' Other Non Operating Income stood at $816086.0 in 2022, then slumped by 85.64% to $117191.0 in 2023, then decreased by 2.38% to $114407.0 in 2024, then sank by 93.88% to $7000.0 in 2025, then sank by 235.59% to -$9491.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$9491.0, $7000.0, and $7000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,491.00 |
| Dec 31, 2025 | 2,293.00 |
| Sep 30, 2025 | -26,250.00 |
| Jun 30, 2025 | 19,464.00 |
| Mar 31, 2025 | -7,171.00 |
| Jun 30, 2024 | 114,407.00 |
| Mar 31, 2024 | 153,218.00 |
| Jun 30, 2023 | 117,191.00 |
| Mar 31, 2023 | -6,388.00 |
| Dec 31, 2022 | -34,367.00 |
| Mar 31, 2022 | 45,000.00 |